223 related articles for article (PubMed ID: 8489239)
41. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
42. Rat liver cytochrome P450 2B3: structure of the CYP2B3 gene and immunological identification of a constitutive P450 2B3-like protein in rat liver.
Jean A; Reiss A; Desrochers M; Dubois S; Trottier E; Trottier Y; Wirtanen L; Adesnik M; Waxman DJ; Anderson A
DNA Cell Biol; 1994 Aug; 13(8):781-92. PubMed ID: 8068203
[TBL] [Abstract][Full Text] [Related]
43. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities.
Brady JF; Li DC; Ishizaki H; Yang CS
Cancer Res; 1988 Nov; 48(21):5937-40. PubMed ID: 3167846
[TBL] [Abstract][Full Text] [Related]
44. Regulation of cytochrome P450 2B1/2 mRNAs by Kepone (chlordecone) and potent estrogens in primary cultures of adult rat hepatocytes on Matrigel.
Kocarek TA; Schuetz EG; Guzelian PS
Toxicol Lett; 1994 Apr; 71(2):183-96. PubMed ID: 7513451
[TBL] [Abstract][Full Text] [Related]
45. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1.
Shu L; Hollenberg PF
Carcinogenesis; 1997 Apr; 18(4):801-10. PubMed ID: 9111218
[TBL] [Abstract][Full Text] [Related]
46. Inhibition and induction of cytochrome P450 2B1 in rat liver by promazine and chlorpromazine.
Murray M
Biochem Pharmacol; 1992 Sep; 44(6):1219-22. PubMed ID: 1417944
[TBL] [Abstract][Full Text] [Related]
47. Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
Kim SG; Reddy SL; States JC; Novak RF
Mol Pharmacol; 1991 Jul; 40(1):52-7. PubMed ID: 1857340
[TBL] [Abstract][Full Text] [Related]
48. Different activation patterns of rat xenobiotic metabolism genes by two constituents of garlic.
Zhang P; Noordine ML; Cherbuy C; Vaugelade P; Pascussi JM; Duée PH; Thomas M
Carcinogenesis; 2006 Oct; 27(10):2090-5. PubMed ID: 16679304
[TBL] [Abstract][Full Text] [Related]
49. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.
Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK
Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558
[TBL] [Abstract][Full Text] [Related]
50. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride.
Fukao T; Hosono T; Misawa S; Seki T; Ariga T
Food Chem Toxicol; 2004 May; 42(5):743-9. PubMed ID: 15046820
[TBL] [Abstract][Full Text] [Related]
51. Correlation between alterations in nucleosomal organization of LINEs in the promoter of cytochrome P450 2B1/2 gene and induction of CYP 2B1/2B2 mRNA expression by phenobarbitone in rat liver.
Dey I; Rath PC
DNA Cell Biol; 2005 Jun; 24(6):359-70. PubMed ID: 15941388
[TBL] [Abstract][Full Text] [Related]
52. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
53. Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan).
Baldwin SJ; Bramhall JL; Ashby CA; Yue L; Murdock PR; Hood SR; Ayrton AD; Clarke SE
Drug Metab Dispos; 2006 Jun; 34(6):1063-9. PubMed ID: 16531474
[TBL] [Abstract][Full Text] [Related]
54. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites.
Brady JF; Ishizaki H; Fukuto JM; Lin MC; Fadel A; Gapac JM; Yang CS
Chem Res Toxicol; 1991; 4(6):642-7. PubMed ID: 1807447
[TBL] [Abstract][Full Text] [Related]
56. Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes.
Haber D; Siess MH; Canivenc-Lavier MC; Le Bon AM; Suschetet M
J Toxicol Environ Health; 1995 Apr; 44(4):423-34. PubMed ID: 7723075
[TBL] [Abstract][Full Text] [Related]
57. Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain.
Parmar D; Dhawan A; Seth PK
Mol Cell Biochem; 1998 Dec; 189(1-2):201-5. PubMed ID: 9879672
[TBL] [Abstract][Full Text] [Related]
58. Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro.
Bars RG; Bell DR; Elcombe CR
Biochem Pharmacol; 1993 May; 45(10):2045-53. PubMed ID: 7685601
[TBL] [Abstract][Full Text] [Related]
59. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
60. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
